1. Home
  2. AAT vs GERN Comparison

AAT vs GERN Comparison

Compare AAT & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAT
  • GERN
  • Stock Information
  • Founded
  • AAT 1967
  • GERN 1990
  • Country
  • AAT United States
  • GERN United States
  • Employees
  • AAT N/A
  • GERN N/A
  • Industry
  • AAT Real Estate Investment Trusts
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAT Real Estate
  • GERN Health Care
  • Exchange
  • AAT Nasdaq
  • GERN Nasdaq
  • Market Cap
  • AAT 1.3B
  • GERN 1.5B
  • IPO Year
  • AAT 2011
  • GERN 1996
  • Fundamental
  • Price
  • AAT $21.84
  • GERN $2.57
  • Analyst Decision
  • AAT Hold
  • GERN Strong Buy
  • Analyst Count
  • AAT 2
  • GERN 11
  • Target Price
  • AAT $26.00
  • GERN $6.82
  • AVG Volume (30 Days)
  • AAT 329.6K
  • GERN 12.4M
  • Earning Date
  • AAT 02-04-2025
  • GERN 02-26-2025
  • Dividend Yield
  • AAT 6.23%
  • GERN N/A
  • EPS Growth
  • AAT 12.42
  • GERN N/A
  • EPS
  • AAT 0.94
  • GERN N/A
  • Revenue
  • AAT $453,339,000.00
  • GERN $29,480,000.00
  • Revenue This Year
  • AAT N/A
  • GERN $31,918.56
  • Revenue Next Year
  • AAT $1.87
  • GERN $289.41
  • P/E Ratio
  • AAT $23.19
  • GERN N/A
  • Revenue Growth
  • AAT 3.79
  • GERN 9199.68
  • 52 Week Low
  • AAT $20.03
  • GERN $1.64
  • 52 Week High
  • AAT $29.15
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • AAT 32.68
  • GERN 31.98
  • Support Level
  • AAT $21.53
  • GERN $2.49
  • Resistance Level
  • AAT $22.60
  • GERN $2.84
  • Average True Range (ATR)
  • AAT 0.50
  • GERN 0.15
  • MACD
  • AAT -0.03
  • GERN -0.01
  • Stochastic Oscillator
  • AAT 11.07
  • GERN 13.33

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: